Get Adobe Flash player

Merck KGaA [Newsroom]
Darmstadt, Germany (ots/PRNewswire) — Two oral presentations and nine posters include new analyses on investigational Cladribine Tablets – Real-world data assess the safety, tolerability and effectiveness of Rebif® – Symposium … Lesen Sie hier weiter…

Original-Content von: Merck KGaA, übermittelt durch news aktuell

Powered by WPeMatico

Kommentare sind geschlossen.